Stockholders' Deficit (Detail) - USD ($) $ in Thousands		3 Months Ended
		Mar. 26, 2023	Mar. 27, 2022
Stockholders' Deficit [Line Items]
Balance	[1]	$ (4,189,065)
Net income		104,770	$ 90,964
Balance		$ (4,151,773)
Common Stock [Member]
Stockholders' Deficit [Line Items]
Balance (in shares)		35,419,718	36,138,273
Balance		$ 354	$ 361
Issuance and cancellation of stock awards, net (in shares)		14,495	340
Tax payments for restricted stock upon vesting, (in shares)		(5,073)	(1,875)
Purchases of common stock, (in shares)		(100,515)	(100,810)
Purchases of common stock		$ (1)	$ (1)
Exercises of stock options, (in shares)		1,508	1,445
Balance (in shares)		35,330,133	36,037,373
Balance		$ 353	$ 360
Additional Paid-in Capital [Member]
Stockholders' Deficit [Line Items]
Balance		9,693	840
Tax payments for restricted stock upon vesting		(1,553)	(789)
Purchases of common stock		(14,547)	(4,037)
Exercises of stock options		343	266
Non-cash equity-based compensation expense		7,538	7,265
Balance		1,474	3,545
Retained Deficit [Member]
Stockholders' Deficit [Line Items]
Balance		(4,194,418)	(4,207,917)
Net income		104,770	90,964
Dividends declared on common stock and equivalents		(43,005)	(39,765)
Purchases of common stock		(15,802)	(43,623)
Balance		(4,148,455)	(4,200,341)
Accumulated Other Comprehensive Income (Loss) [Member]
Stockholders' Deficit [Line Items]
Balance		(4,694)	(2,820)
Currency translation adjustment		(451)	614
Balance		$ (5,145)	$ (2,206)

[1] The condensed consolidated balance sheet at January 1, 2023 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.